# Exela Pharma Sciences LLC - Inspection Records Source: https://www.keypedia.com/companies/exela-pharma-sciences-llc/4e6f3b32-adeb-41f4-b9dd-a8e7784569b3 > Inspection records and compliance data for Exela Pharma Sciences LLC in Lenoir, North Carolina. Access full analysis and detailed observations. --- ## Details - Name: Exela Pharma Sciences LLC - FEI Number: 3008563008 - City: Lenoir - State: North Carolina - Country Name: United States - Address Line 1: 1245 Blowing Rock Blvd - Zip Code: 28645 - Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK ## Related Documents - [483 - Exela Pharma Sciences LLC - 2024-11-15](https://www.keypedia.com/records/483/exela-pharma-sciences-llc/73b962be-d31b-4dda-9a43-684980099547) — source: FDA, date: November 15, 2024 - [483 - Exela Pharma Sciences LLC - 2024-11-15](https://www.keypedia.com/records/483/exela-pharma-sciences-llc/2062d19a-4e2b-44db-976c-0d8b11328b9f) — source: FDA, date: November 15, 2024 - [483 - Exela Pharma Sciences LLC - 2024-11-15](https://www.keypedia.com/records/483/exela-pharma-sciences-llc/60077e2a-4655-4ff7-84ff-713e02f8a6b0) — source: FDA, date: November 15, 2024 - [WARNING_LETTER - Exela Pharma Sciences LLC - 2024-11-15](https://www.keypedia.com/records/warning_letter/exela-pharma-sciences-llc/832d5d8c-294f-4c3e-9653-35170b74e857) — source: FDA, date: November 15, 2024 - [483 - Exela Pharma Sciences LLC - 2024-11-15](https://www.keypedia.com/records/483/exela-pharma-sciences-llc/7fa0eb4d-d50b-495c-9096-18866220d8af) — source: FDA, date: November 15, 2024 - [FDA Inspection 1256957 - Exela Pharma Sciences LLC - 2024-11-15](https://www.keypedia.com/records/fda_inspections/exela-pharma-sciences-llc/75c7f1e7-b82d-4fec-b497-f6c7b6c3fab8) — source: FDA, date: November 15, 2024 - [FDA Inspection 1256957 - Exela Pharma Sciences LLC - 2024-11-15](https://www.keypedia.com/records/fda_inspections/exela-pharma-sciences-llc/c49bbdca-1ca9-482e-af5f-49658d2feb1c) — classification: Official Action Indicated (OAI), source: FDA, date: November 15, 2024 - [483 - Exela Pharma Sciences LLC - 2024-11-04](https://www.keypedia.com/records/483/exela-pharma-sciences-llc/5de8eeaa-193a-42b9-94b5-06662a319921) — source: FDA, date: November 4, 2024 - [483 - Exela Pharma Sciences LLC - 2024-11-04](https://www.keypedia.com/records/483/exela-pharma-sciences-llc/bc618c55-02a7-4815-8657-992fe5c2d7e4) — source: FDA, date: November 4, 2024 - [EIR - Exela Pharma Sciences LLC - 2019-10-22](https://www.keypedia.com/records/eir/exela-pharma-sciences-llc/1ff0bf60-f6da-4f02-ac0b-9fa76949550e) — source: FDA, date: October 22, 2019 - [EIR - Exela Pharma Sciences LLC - 2019-07-18](https://www.keypedia.com/records/eir/exela-pharma-sciences-llc/fde33740-f408-45e3-b239-f89a94247474) — source: FDA, date: July 18, 2019 - [WARNING_LETTER - Exela Pharma Sciences LLC - 2019-07-18](https://www.keypedia.com/records/warning_letter/exela-pharma-sciences-llc/7cf4c257-966b-464d-879f-fd23e25eae1c) — source: FDA, date: July 18, 2019 - [FDA Inspection 1096634 - Exela Pharma Sciences LLC - 2019-07-18](https://www.keypedia.com/records/fda_inspections/exela-pharma-sciences-llc/158d466d-f3a8-44b8-83e0-cf8497d372f6) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 18, 2019 - [FDA Inspection 1081405 - Exela Pharma Sciences LLC - 2018-12-19](https://www.keypedia.com/records/fda_inspections/exela-pharma-sciences-llc/b1e440fb-dc27-4b47-b6cb-b767a36b64d9) — classification: No Action Indicated (NAI), source: FDA, date: December 19, 2018 - [FDA Inspection 1067755 - Exela Pharma Sciences LLC - 2018-09-11](https://www.keypedia.com/records/fda_inspections/exela-pharma-sciences-llc/04fb85de-d9ad-4cdf-b407-5e409c65b64c) — classification: No Action Indicated (NAI), source: FDA, date: September 11, 2018 - [FDA Inspection 1026858 - Exela Pharma Sciences LLC - 2017-09-28](https://www.keypedia.com/records/fda_inspections/exela-pharma-sciences-llc/b2f6d327-c123-48d0-9650-b494e5151266) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 28, 2017 - [FDA Inspection 988490 - Exela Pharma Sciences LLC - 2016-06-08](https://www.keypedia.com/records/fda_inspections/exela-pharma-sciences-llc/2da7002e-f05d-43fa-a427-a0117c3e2ca4) — classification: No Action Indicated (NAI), source: FDA, date: June 8, 2016 - [FDA Inspection 906470 - Exela Pharma Sciences LLC - 2014-11-21](https://www.keypedia.com/records/fda_inspections/exela-pharma-sciences-llc/3cff58d4-a972-40e4-b2c8-8d44a67b2e1b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 21, 2014 - [FDA Inspection 893626 - Exela Pharma Sciences LLC - 2014-08-28](https://www.keypedia.com/records/fda_inspections/exela-pharma-sciences-llc/af7923fe-a410-40ce-bb1b-025b2d211ad0) — classification: No Action Indicated (NAI), source: FDA, date: August 28, 2014 - [FDA Inspection 849770 - Exela Pharma Sciences LLC - 2013-04-12](https://www.keypedia.com/records/fda_inspections/exela-pharma-sciences-llc/7f2bce59-2fd8-4458-9d73-a50ecc686466) — classification: No Action Indicated (NAI), source: FDA, date: April 12, 2013 ## Related Companies - [Celltrion Inc.](https://www.keypedia.com/companies/celltrion-inc/d3991ec8-423b-4554-9d67-72bc27a8658b) - [Serum Institute of India Pvt. Ltd.](https://www.keypedia.com/companies/serum-institute-of-india-pvt-ltd/a1288932-02ec-49e6-942a-e8d90c93b890) - [Abeona Therapeutics, Inc.](https://www.keypedia.com/companies/abeona-therapeutics-inc/9f67747d-0cf7-495e-a7d5-a4abfa60671a) - [Akeso Biopharma Co., Ltd.](https://www.keypedia.com/companies/akeso-biopharma-co-ltd/5e7be927-b0ec-4dd3-83d6-9a9bd61cf75b) - [Jiangsu Hansoh Pharmaceutical Group Co., Ltd](https://www.keypedia.com/companies/jiangsu-hansoh-pharmaceutical-group-co-ltd/05c8e8c4-3ef9-4644-9f70-ddabbded9eec) - [Biotest AG](https://www.keypedia.com/companies/biotest-ag/a9ea8ef4-79ad-47e6-a0a9-c434d0a69869) - [IDT Biologika GmbH](https://www.keypedia.com/companies/idt-biologika-gmbh/ec3af185-e1cd-4ce4-9268-6cbfb25fa986) - [SUNNY PHARMTECH INC.](https://www.keypedia.com/companies/sunny-pharmtech-inc/ef1ee573-efce-4b46-a67b-b9dfafc78f82) - [Lonza Houston, Inc](https://www.keypedia.com/companies/lonza-houston-inc/c3ae4db9-9aba-4b65-9e2b-06e1632112a6) - [Berkshire Sterile Manufacturing, LLC](https://www.keypedia.com/companies/berkshire-sterile-manufacturing-llc/122082ed-d7d0-478b-8280-8fd8bad790b2) ## Related Officers - [ Drug Investigator](https://www.keypedia.com/people/samantha-j-bradley/ba45f64f-07a9-4933-833f-b9b339c57783) - [Joan Cantellops](https://www.keypedia.com/people/joan-cantellops/fc262236-5a32-40d8-bc37-3e8505badbaa) - [Joan M. Cantellops Figueroa](https://www.keypedia.com/people/joan-m-cantellops-figueroa/f791fcd2-a5d4-41e8-a8f2-96569096b422) - [ CSO](https://www.keypedia.com/people/megan-t-ziegler/3e83a317-701a-4e40-bb43-34d294d3448f) - [Vice President Clinical and Regulatory Affairs](https://www.keypedia.com/people/aruna-koganti/4760c049-6d4b-46a4-94fb-477afd8708ed)